|Articles|October 1, 1999

New Products

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

FAQ: What does the new AAP iron deficiency guidance mean for your practice?

PCOS to PMOS: A long-awaited change

Can you guess the diagnosis of this 17-year-old male with loss of consciousness during a febrile illness?

Infant Gut Microbiome at Birth: Why Early Colonization Matters

CDC declares Nara Organics infant botulism outbreak over as genetic testing links it to 2025 ByHeart outbreak